연성 내시경 시장 보고서 : 제품 유형별, 시술 유형별, 최종 사용자별, 지역별(2026-2034년)

The global flexible endoscopes market size reached USD 9.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 15.2 Billion by 2034, exhibiting a growth rate (CAGR) of 5.41% during 2026-2034. The increasing prevalence of gastrointestinal and respiratory diseases, global rise in the geriatric population, growing preference for minimally invasive procedures among patients and healthcare providers, and rising awareness and screening programs for numerous gastrointestinal and respiratory conditions represent some of the key factors driving the market.

Flexible endoscopes are medical instruments used in minimally invasive procedures to visually examine and diagnose conditions inside the body. They consist of a long, flexible tube with a light source and a camera at the tip. The flexible design allows the endoscopes to navigate through the body's natural passages, such as the gastrointestinal tract or respiratory system, providing access to hard-to-reach areas. The camera captures high-quality images or videos, which are transmitted to a monitor for real-time visualization by medical professionals. Flexible endoscopes are commonly used in various diagnostic and therapeutic procedures, including gastrointestinal endoscopy, bronchoscopy, and colonoscopy. Their flexibility allows for easier maneuverability, reducing patient discomfort and potential tissue damage. These devices have revolutionized medical practices by offering a less invasive alternative to traditional surgery, enabling physicians to make accurate diagnoses, perform biopsies, remove small polyps, and deliver targeted treatments directly to affected areas while minimizing patient trauma and enhancing recovery times.

FLEXIBLE ENDOSCOPES MARKET TRENDS:

One of the primary factors driving the market is the increasing prevalence of gastrointestinal and respiratory diseases, like gastrointestinal cancers, gastrointestinal bleeding, inflammatory bowel disease, chronic obstructive pulmonary disease, and lung cancer, which require regular monitoring, diagnosis, and treatment. Flexible endoscopes enable healthcare professionals to access and visualize these areas for accurate diagnosis and targeted intervention. Additionally, the global rise in the geriatric population endoscopes more prone to gastrointestinal and respiratory disorders has resulted in frequent endoscopic examinations, thus accelerating the product adoption rate. Other than this, there is a growing preference for minimally invasive procedures among patients and healthcare providers as these techniques offer several advantages over traditional surgery, including reduced trauma, shorter hospital stays, faster recovery times, and improved patient outcomes. Flexible endoscopes enable healthcare professionals to perform diagnostic and therapeutic interventions with minimal invasiveness, making them a preferred choice for both patients and physicians. Besides this, increasing awareness and screening programs for various gastrointestinal and respiratory conditions drive the demand for flexible endoscopes. Moreover, advancements in technology have led to the development of more advanced and sophisticated flexible endoscopes with high-definition imaging capabilities, improved maneuverability, enhanced visualization, and the integration of complementary technologies such as narrow-band imaging (NBI) and fluorescence imaging. These innovations are providing healthcare professionals with better diagnostic tools and improved patient outcomes.

KEY MARKET SEGMENTATION:

Product Type Insights:

• Fiberscope
• Videoscope

Procedure Type Insights:

• Gastroscopy
• Colonoscopy
• Bronchoscopy
• Ureteroscopy
• Others

End User Insights:

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Others

Regional Insights:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for flexible endoscopes. Some of the factors driving the North America flexible endoscopes market included technological advancements, increasing prevalence of gastrointestinal diseases, and growing adoption of minimally invasive procedures.

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the global flexible endoscopes market. Detailed profiles of all major companies have been provided. Some of the companies covered include Ambu A/S, ATMOS MedizinTechnik GmbH & Co. KG, Becton Dickison and Company, Boston Scientific Corporation, EndoMed Systems GmbH, Karl Storz SE and Co. KG, Laborie Medical Technologies Inc., Olympus Corporation, Pentax of America Inc. (Hoya Corporation), Richard Wolf GmbH, Scholly Fibreoptic GmbH (Aesculap AG), SonoScape Medical Corp, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

KEY QUESTIONS ANSWERED IN THIS REPORT

• How has the global flexible endoscopes market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global flexible endoscopes market?
• What is the impact of each driver, restraint, and opportunity on the global flexible endoscopes market?
• What are the key regional markets?
• Which countries represent the most attractive tea market?
• What is the breakup of the market based on the product type?
• Which is the most attractive product type in the flexible endoscopes market?
• What is the breakup of the market based on the procedure type?
• Which is the most attractive procedure type in the flexible endoscopes market?
• What is the breakup of the market based on the end user?
• Which is the most attractive end user in the flexible endoscopes market?
• What is the competitive structure of the global flexible endoscopes market?
• Who are the key players/companies in the global flexible endoscopes market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Flexible Endoscopes Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product Type

• 6.1 Fiberscope
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Videoscope
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Procedure Type

• 7.1 Gastroscopy
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Colonoscopy
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Bronchoscopy
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Ureteroscopy
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Others
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals and Clinics
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Ambulatory Surgical Centers
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Others
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

• 10.1 Overview
• 10.2 Drivers
• 10.3 Restraints
• 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Ambu A/S
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 ATMOS MedizinTechnik GmbH & Co. KG
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Becton Dickinson and Company
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Boston Scientific Corporation
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 EndoMed Systems GmbH
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Karl Storz SE and Co. KG
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 SWOT Analysis
  • 14.3.7 Laborie Medical Technologies Inc.
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Olympus Corporation
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 Pentax of America Inc. (Hoya Corporation)
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Richard Wolf GmbH
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 SWOT Analysis
  • 14.3.11 Scholly Fibreoptic GmbH (Aesculap AG)
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
  • 14.3.12 SonoScape Medical Corp.
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
    • 14.3.12.3 Financials